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Abstract
Adipose tissue development begins in utero and is a key target of developmental program-
ming. Here the influence of nutritionally-mediated prenatal growth-restriction on perirenal adi-
pose tissue (PAT) gene expression and adipocyte phenotype in late fetal life was investigated
in both sexes in an ovine model. Likewise circulating leptin concentrations and non-esterified
fatty acid (NEFA) and glycerol responses to glucose challenge were determined in relation
to offspring adiposity at key stages from birth to mid-adult life. In both studies’ singleton-bear-
ing adolescent sheep were fed control or high nutrient intakes to induce normal or growth-
restricted pregnancies, respectively. Fetal growth-restriction at day 130 of gestation (32% ligh-
ter) was characterised by greater body-weight-specific PAT mass and higher PAT expression
of peroxisome proliferator-activated receptor gamma (PPARɤ), glycerol-3-phosphate dehydro-
genase, hormone sensitive lipase (HSL), insulin-like growth factor 1 receptor, and uncoupling
protein 1. Independent of prenatal growth, females had a greater body-weight-specific PAT
mass, more multilocular adipocytes, higher leptin and lower insulin-like growth factor 1 mRNA
than males. Growth-restricted offspring of both sexes (42% lighter at birth) were characterised
by higher plasma NEFA concentrations across the life-course (post-fasting and after glucose
challenge at 7, 32, 60, 85 and 106 weeks of age) consistent with reduced adipose tissue insu-
lin sensitivity. Circulating plasma leptin correlated with body fat percentage (females>males)
and restricted compared with normal females had more body fat and increased abundance of
PPARɤ;, HSL, leptin and adiponectin mRNA in PAT at necropsy (109 weeks). Therefore, pre-
natal nutrient supply and sex both influence adipose tissue development with consequences
for lipid metabolism and body composition persisting throughout the life-course.
Introduction
Appropriate prenatal adipose tissue development to facilitate non-shivering thermogenesis at
birth is fundamental to the immediate survival of precocial mammals [1,2]. Thereafter adipose
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tissue is central to energy metabolism and developmentally programmed alterations in adipose
tissue physiology are considered a common phenotypic feature underlying a range of issues
that become apparent in postnatal life [3]. In humans these include metabolic, cardiovascular
and reproductive disorders [4–6], while in meat producing species excess body fat negatively
impacts meat quality and hence financial returns to the producer [7,8].
In humans and sheep, fat is mainly deposited around the fetal kidneys from mid-pregnancy
onwards, and by late gestation this perirenal adipose tissue (PAT) depot contains both uniloc-
ular (white-lipid storage) and multilocular (brown-thermogenic) adipocytes [9–11]. The latter
cells are mitochondria-rich and high levels of uncoupling protein 1 (UCP1) burn fatty acids
and glucose to release heat in the newborn [12]. Immediately after birth the PAT depot of
lambs is transiently depleted of lipid and as the neonate suckles and grows the brown adipo-
cytes are lost and white lipid-filled adipocytes dominate [11]. In adult life, humans and sheep
are similar with respect to mature body weight and adiposity.
Maternal dietary intake is a key driver of fetal nutrient supply and as such is likely to play an
important role in establishing the size of the prenatal PAT depot and its cellular make-up, with
potential consequences for metabolism and body composition across the life-course. In spite
of this assertion sheep models involving either under- or over-nourishing adult dams during
defined periods of pregnancy have failed to reach a consensus with regard to the impact of
altered nutrient supply on fetal growth, PAT depot mass or expression of genes involved in
adipose tissue growth, differentiation or function when measured in late gestation [13–20].
This may reflect inconsistencies both between and within studies with respect to maternal par-
ity, dietary history, numbers of rams used, fetal number, sex distribution and season [2]. Most
of these factors are kept constant in our adolescent sheep models: these involve assisted concep-
tion procedures using one sire and transfer of single high-quality embryos harvested from
donors with a known nutritional and reproductive background into young primiparous adoles-
cent recipients of equivalent age, weight and adiposity at conception. Thereafter the adolescents
are nutritionally manipulated throughout gestation with the control or reference group being
mothers whose initial adiposity level is maintained all the way through. In the undernourished
model, further maternal growth during pregnancy is prevented and the gradual depletion of
her body reserves limits fetal nutrient supply, independent of any change in placental size [21].
By late gestation the fetuses are modestly lighter with lower PAT mass and fewer unilocular adi-
pocytes [22].
Our focus here is our overnourished model where a high dietary intake throughout gestation
promotes continued maternal growth and increased adiposity but where placental growth,
uteroplacental blood flows and fetal nutrient delivery are attenuated leading to a high inci-
dence of marked fetal growth-restriction by late gestation [reviewed in 23]. These effects have
proved robust across multiple studies with ~50% of offspring of overnourished mothers having
a birthweight >2SD below the mean birthweight of the normally-growing reference group.
Studying the relative development of the fetal adipose tissue in these pregnancies is particularly
pertinent as the lambs are born prematurely (~5 days early), and initial colostrum supply is
severely impaired, making them vulnerable to hypothermia and starvation. We hypothesised
that this form of nutritionally-induced placental insufficiency and poor fetal nutrient supply
would impact the size and adipocyte composition of the fetal PAT depot and this would be
associated with changes in the expression of selected molecular markers of adipocyte prolifera-
tion, differentiation and function (Experiment 1). We further postulated that the adipose tissue
phenotype of prenatally growth-restricted lambs would influence their postnatal lipid metabo-
lism and body composition, and accordingly we measured circulating leptin concentrations
and non-esterified fatty acid (NEFA) and glycerol responses to glucose challenge in relation
to offspring adiposity at key stages from birth to mid-adult life (Experiment 2). Given the
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pronounced sexually dimorphic responses reported postnatally in the ovine nutritional pro-
gramming literature [24–30], both studies were sufficiently large to allow the impact of fetal or
offspring sex to be examined.
Materials and methods
Establishment of pregnancy and nutritional management
All procedures were licensed under the UK Animals (Scientific Procedures) Act of 1986 and
approved by the Rowett Institute’s Ethical Review Committee. Ewes were housed in individual
open-wide bar pens that facilitated nose to nose contact with neighbouring animals, under nat-
ural lighting conditions at 57˚N, 2˚W. Singleton pregnancies were generated following super-
ovulation and laparoscopic intrauterine insemination (single Dorset Horn sire) of adult donor
ewes (third parity, Border Leicester x Scottish Blackface, mean adiposity score 2.3 units), and
synchronous transfer of the resulting embryos into adolescent recipients (~8.5 months old,
Dorset Horn x Greyface) of similar initial weight and adiposity. For recipients, oestrus synchro-
nisation commenced on Day -15 relative to the onset of oestrus (Day 0) by insertion of vaginal
sponges containing 60mg medroxyprogesterone acetate (Veramix1, Intervet UK Ltd, Welwyn
Garden City, Herts, UK). Thirteen days later (Day -2) at 14:00h, sponges were removed, and
ovulation stimulated by i.m. administration of 600 iu pregnant mare serum gonadotrophin
(PMSG, Intervet UK Ltd). For donor ewes, synchronisation commenced on Day -14, when
vaginal sponges containing 40mg fluorogestone acetate (Chronogest1, Intervet UK Ltd) were
inserted. Seven days later (Day -7) these sponges were removed and immediately replaced with
fresh ones of the same type. A superovulation regime was commenced on Day -4 at 08:00h
with the i.m. administration of 1.125mg ovine follicle-stimulating hormone (oFSH, Ovagen1,
Immuno-Chemical Products Ltd, Auckland, New Zealand) immediately followed by 125μg IM
cloprostenol (Estrumate1, Schering-Plough Ltd, Welwyn Garden City, Herts, UK), a synthetic
prostaglandin-F2α. At 18:00h a second dose of oFSH was given together with 400iu PMSG.
Further twice daily doses of oFSH were administered at 08:00h and 18:00h on the following
three days (Day -3 to -1) and sponges were removed on Day -2 at 18:00h. The onset of oestrus
was assessed by presenting females to vasectomised rams three times daily to ensure optimum
synchrony between potential donor and recipient animals. On Day 0 at 16:00h, donor ewes
underwent insemination directly into the uterine cavity under direct laparoscopic visualisation,
as previously described [31]. In both studies this involved fresh semen, collected by artificial
vagina from the same sire of proven fertility, and diluted 1:3 with phosphate-buffered saline.
Approximately 0.3ml of diluted semen was deposited in each horn. Four days following insemi-
nation, multiple embryos were recovered from donor ewes at laparotomy using a standard sur-
gical technique of retrograde flushing of each oviduct. This was achieved by advancing a fine
glass cannula into the fimbria, injecting ovum culture media (ICN Biomedicals, Ohio, USA)
warmed to 37˚C into the lumen of the ipsilateral uterine horn ~ 5cm from the utero-tubal junc-
tion and milking the media out through the cannula into a sterile glass embryo dish. Develop-
mental stage and quality were assessed using a stereomicroscope and the embryos held at 33˚C
in fresh ovum culture media until transferred to recipients within 4h of recovery. Embryos of
optimum quality and stage were synchronously transferred in singleton into the uteri of adoles-
cent recipients using a laparoscopically-assisted technique. Ovulation rate was determined, and
the embryo transferred into the tip of the uterine horn ipsilateral to the ovary with the greater
number of corpora lutea.
In Experiment 1 (fetal study), the adolescent recipients had a mean liveweight of 44.3
±0.34kg, and an adiposity score of 2.3±0.01 (equivalent to 23% body fat, based on a 5-point
scale, where 1 = emaciated and 5 = extremely obese; [32]) at the time of embryo transfer. In
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Experiment 2 (postnatal study) recipient liveweight and adiposity score were 46.6±1.09kg and
2.3±0.04 units, respectively.
In both experiments, and commencing directly after embryo transfer, adolescent recipients
were offered either a control or high level of a complete diet providing 12 MJ of metabolisable
energy (ME) and 140 g of crude protein per kg. Diet composition was 30% coarsely milled
hay, 41.5% barley 17.5% Hipro soya, 10% molasses, 0.35% salt, 0.25% limestone, 0.25% dical-
cium phosphate and 0.15% of a vitamin-mineral mix [33]. Fresh food was offered in two daily
feeds at 08:00h and 16:00h. For the control group the dietary level was calculated to preserve
the original maternal adiposity level throughout pregnancy and to provide 100% of the esti-
mated metabolisable energy and protein requirements of the adolescent sheep carrying a sin-
gleton fetus according to stage of pregnancy ([34]; normal fetoplacental growth). In contrast,
the high ration which was fed ad libitum, was intended to support continued maternal growth
and increasing adiposity at the expense of the conceptus: to achieve this, recipients had the
ration increased stepwise over a 2-week period until the daily food refusal was ~15% of the
amount offered. These animals were considered overnourished (~2.25 x control). To facilitate
accurate nutritional management external adiposity scores and weights were measured fort-
nightly throughout pregnancy.
Experimental design
In Experiment 1 viable pregnancies were established in 28 control and 32 overnourished dams
(measured by transabdominal ultrasound at d45 and d90). A maternal blood sample was col-
lected just before necropsy on day 130 of gestation and the plasma used to confirm metabolic
status (glucose, insulin and NEFA concentrations). Ewes were killed by i.v. sodium pentobar-
bitone (20ml Euthesate; 200mg pentobarbitone/ml; Willows Francis Veterinary, Crawley, UK)
and exsanguination. The gravid uterus was weighed, opened, and fetal blood sampled by car-
diac puncture immediately before administering intracardiac sodium pentobarbitone (3ml
Euthesate); this plasma was analysed for insulin. The fetus was dried and weighed, and the
PAT rapidly dissected free from the kidneys. PAT was weighed and samples either snap-frozen
in isopentane chilled by liquid nitrogen and stored at -80˚C pending gene expression analysis
(n = 12 genes) or fixed in 10% neutral buffered formalin and embedded in paraffin for histo-
logical quantification of adipocytes. Intact placentomes were dissected and weighed as was the
fetal brain, fetal liver and maternal carcass: these weights helped confirm the efficacy of the
nutritional treatments.
A full description of the derivation of the postnatal animals studied in the course of Experi-
ment 2 has been reported elsewhere with respect to pregnancy outcome, neonatal care and
postnatal management [35]. Briefly 24 normal birthweight lambs from control-fed ewes (12
females and 12 males) and 25 growth-restricted lambs from overnourished ewes (16 females
and 9 males) were studied from birth forwards. Males remained gonad intact. During lactation
the mothers were fed the complete diet described above ad libitum. Offspring (lambs) were
weaned at 11 weeks of age and had free unlimited access to the complete diet throughout post-
natal life. Offspring underwent intravenous glucose tolerance tests (GTT) at 7, 32, 60, 85 and
106 weeks of age as previously described for suckling [29] and adult life-stages [36]. At the
7-week stage this involved a 3 hour fast prior to i.v. glucose being administered at 0.25g/kg
body weight. At subsequent ages offspring were fasted overnight for 18.5 hours prior to i.v. glu-
cose at 0.5g/kg body weight. Blood samples were collected at -30, -15, 0, +5, +10, +15, +30, +45,
+60, 90 and +120 minutes at 7 weeks of age and a further sample was collected at +180 minutes
at all other stages. Insulin and glucose responses have already been reported and herein NEFA
and glycerol were measured. Fasting levels (baseline), slope (from 10 to 30 minutes), and areas
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under the response curve (AUC) were determined. AUC was calculated as integrated plasma
concentrations following glucose administration [5–120 or 5–180 minutes overall, for 7 weeks
versus all other stages, respectively] above the mean baseline [-30 to 0 minutes] concentrations.
In addition, venous blood samples collected at ~11:00h were collected at weekly then fortnightly
intervals throughout the life-course and leptin concentrations measured in the resulting plasma.
Plasma leptin and adiponectin were also measured in a blood sample collected immediately
before necropsy. Body composition was determined by dual energy X-ray absorptiometry
(DEXA) under general anaesthesia at 11, 41, 64 and 107 weeks of age as previously described
[35]. The body fat data are reproduced here to facilitate comparison with peripheral leptin
concentrations, and both the body fat and bone mineral density data were used in an analysis
(detailed below) to estimate body composition at birth and the average change thereafter. Off-
spring were killed at 109–110 weeks of age as specified above and the major organs dissected.
The PAT was weighed, sampled as for the fetal study and the expression of 10 genes
determined.
Fetal adipocyte histology
The procedure used to quantify the density of unilocular and multilocular cells in fetal PAT
collected in Experiment 1 was similar to that reported previously [37]. Sections were cut
(5μm), dried overnight, stained with haematoxylin and eosin, and viewed at 200x magnifica-
tion using a Leica microscope. Ten separate complete fields of view per animal, ~1mm apart
on a single section, were captured by digital camera and the images analysed using Image-
Pro Plus (version 4.5.1, Media Cybernetics, Inc., Silver Spring, MD, USA). Standard point
counting techniques [38] were employed: a standard grid was used to determine the adipose
tissue component (i.e. unilocular or multilocular cell) falling below each of 45 grid points
per image, thus totalling 450 points per animal. The volume density (Vd) of each cell type
was calculated as Vd = N/T, where N is the number of points falling on unilocular or multilo-
cular cells, and T is the total number of points counted. The total mass of the unilocular or
multilocular component was calculated by multiplying the Vd of each component by the
PAT mass. Relative unilocular (or multilocular) fat mass (g/kg fetus) was determined by
dividing by fetal weight. For each image the circumference of the largest unilocular cell per
field of view was measured by manual tracing. This was used to generate an overall mean for
the 10 fields of view examined per animal. The above adipose tissue cell types and circumfer-
ence measurements were also quantified on a quality control slide on 10 occasions (~
between every 6th animal) and the resulting coefficients of variation for the 3 parameters
ranged from 2–3%.
Plasma analysis
Plasma insulin and leptin concentrations were measured in duplicate by radioimmunoassay
[39,40]. The sensitivities of the assays were 0.17ng insulin/ml and 0.1ng leptin/ml and inter-
and intra-assay coefficients of variation where applicable were less than 10%. Adiponectin con-
centrations were measured in duplicate using a sheep specific Elisa accordingly to the manu-
facturer’s instructions (Catalogue number CSB-EL001366SH, www.cusabio.co). Samples were
diluted 200 x, sensitivity was 0.6μg adiponectin/ml and duplicate variation was <10%. Plasma
NEFA and glycerol concentrations were measured using an automated clinical analyzer with
kits supplied by the manufacturer (Labmedics, Manchester, UK, duplicate variation <10%),
and glucose by dual-biochemistry analyser (YSI model 2700, Yellow Springs, OH, USA; dupli-
cate variation <3%).
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Quantitative real-time reverse transcription-polymerase chain reaction
analysis
Messenger RNA for genes variously involved in adipocyte proliferation, differentiation and
function were measured by quantitative real-time reverse transcription-polymerase chain reac-
tion (qRT-PCR). Thus PPARɤ;, glycerol-3-phosphate dehydrogenase (G3PDH), lipoprotein
lipase (LPL), fatty acid synthase (FASN), HSL, leptin, adiponectin, IGF1 and IGF2 were mea-
sured in PAT from both fetal and postnatal studies; UCP1, IGF1-R and IGF2-R were measured
in fetal tissue only and INS-R was measured in postnatal tissue only. Probe and primer sets for
sheep-specific sequences of these genes were predominately as previously described [30,41].
The sequences of the cDNA forward and reverse primers and the Taqman probes for genes
not reported previously were as follows: adiponectin, 5'- ACGGCACCACTGGCAAA-3'
(accession number KJ159213), 5'- TAGACGGTAATGTGGTAGGAGAAGTAGT-3' and
5'(6FAM)- TCCTCTGCAATATCCCCGGGCTG-(TAMRA)3', respectively; INS-R, 5'- A
CCGCCAAGGGCAAGAC -3' (accession number AJ844652.1), 5'- AGCACCGCTCCACAA
ACTG -3' and 5'(6FAM)- AACTGCCCTGCCACTGTCATCAACG -(TAMRA)3', respec-
tively. In brief total RNA was extracted from 100mg frozen PAT using RNeasy Lipid Tissue
Mini Kit (Qiagen, Crawley, West Sussex, UK). The quality and quantity of total RNA were
determined via capillary electrophoresis using an Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Wilmington, DE, USA). Real-time RT-PCR reagents, probes, and primers were pur-
chased from and used as recommended by Applied Biosystems (Warrington, UK). For each
sample 54ng total RNA was subjected to reverse transcription (RT) in triplicate to generate
first-strand cDNA using Taqman Reverse Transcription Reagents and Multiscribe Reverse
Transcriptase. Polymerisation and amplification reactions for each RT sample were performed
in duplicate in 20μl final volume using the Applied Biosystems 7500 Fast Real-Time PCR sys-
tem. Quantification was performed by means of a relative standard curve method with serial
dilutions of reference standard cDNA produced from RNA pooled from PAT of control and
overnourished fetuses (Experiment 1, n = 3 per nutritional group and sex) or from control and
prenatally growth-restricted adult offspring (Experiment 2, n = 3 per birthweight category
and sex). Individual mRNA levels of genes of interest were expressed relative to the sample’s
own internal 18S RNA, determined using human 18S Pre-developed TaqMan Assay Reagents.
Within studies samples were randomised to ensure that each nutritional treatment/ growth
category and sex was represented in each 96-well plate. A quality control sample generated
from the study-specific RNA pool was run on each plate and used to calculate inter- and intra-
assay coefficients of variation (cov). Intra-plate cov varied for individual genes varied from 3.6
to 8.1% (overall mean±sem, 5.7±0.42%) and inter- plate cov varied from 0.9 to 9.8% (overall
mean±sem 4.9±0.85%).
Power calculation
The power calculation for the fetal study was based on the prediction that maternal overnutri-
tion would impact fetal weight specific perirenal fat deposition by late gestation. This indicated
that 25 animals per group would be required for the study to have 90% power to detect (at 5%
significance) a 20% change in perirenal fat mass of 0.98 g/kg fetus assuming animal variability
of 1.04 g/kg fetus. This was based on fetal perirenal fat mass data from a mixed population of
female and male fetuses from control-fed pregnancies of equivalent genotype to that used here
and at the same stage of gestation. The power calculation did not consider the sex of the fetus
which was out-with our control but instead assumed that the sex distribution would be broadly
similar within the nutritional treatment groups and thereby allow fetal sex to be included as a
factor in the subsequent analysis. The power calculation for the postnatal study was based on
Prenatal growth-restriction and sex influence adiposity and lipid metabolism
PLOS ONE | https://doi.org/10.1371/journal.pone.0228732 February 14, 2020 6 / 27
previous studies that demonstrate that overnourishing pregnant adolescents negatively
impacts lamb birthweight independent of sex. We assumed a similar number of females and
males would be produced within each nutritional treatment group and thus 11 animals of each
sex per group were selected in order for the study to have 90% power to detect a 20% decrease
in birthweight of 1085g, assuming animal variability of 748g. This was based on lamb birth-
weight data from control-fed pregnancies of equivalent genotype and summarized for several
studies [23]. Embryo transfer is used to derive the viable pregnancies in this animal model and
although we estimate the average conception rate to embryo transfer as ~70% and build in a
loss-to-study at this initial stage, the overall conception rate can vary between studies, and
accordingly, it is our practice to study all available animals irrespective of the power
calculation.
Data analysis
Data are presented as means ± standard error of the mean (SEM) and all statistical comparisons
were made using Minitab (version 19; Minitab Inc., State College, PA). The individual animal
data underlying these means are available (S1 and S2 Tables). All data were checked for nor-
mality using an Anderson-Darling test. Where the P value was<0.05, this was due to positively
skewed distributions and so the data were log transformed before analysis. In Experiment 1
the fetuses of overnourished dams were classified as growth-restricted when fetal weight at
necropsy was>2SD below the genetically-matched control group mean; the cut-off was 3676g
(n = 16). The remaining overnourished fetuses were considered non-restricted (n = 16). The
three groups (control [n = 28], non-restricted and restricted) were compared using one-way
ANOVA for the maternal data (Table 1) and for selected fetal data when females and males
were considered together as presented in the text. The fetal data presented in Tables 2 and 3
were compared by a general linear model (GLM) ANOVA as this approach allowed the effects
of maternal gestational intake/growth status and sex, and their potential interaction to be com-
pared. Post hoc comparisons (Tukey’s method) were used to further differentiate between
groups in both cases. Within individual groups paired Student’s t tests were used to determine
differences in fetal adipocyte cell type.
In Experiment 2 offspring variables measured at several ages throughout the life-course
were primarily analyzed using a mixed-effects repeated-measures model with offspring number
Table 1. Maternal weight and adiposity change, and metabolic status at day 130 of gestation in relation to maternal nutrition and prenatal growth category (Experi-
ment 1).
Gestational intake Control Overnourished P valueß
Growth status Normal Non-Restricted Restricted
Number of pregnancies 28 16 16
Delta maternal weight¥, Kg 9.9±0.51a 29.8±0.78b 30.1±1.08b <0.001
Delta maternal BCSþ, units 0±0.0a 0.6±0.03b 0.6±0.03b <0.001
Maternal carcass weight, Kg 36.3±1.02a 51.3±0.86b 50.9±0.75b <0.001
Maternal insulin, ng/ml 0.9±0.08a 2.1±0.20b 2.1±0.17b <0.001
Maternal glucose, mmol/l 3.1±0.09a 3.6±0.09b 3.5±0.12ab 0.001
Maternal NEFA, mmol/l 0.300±0.0360a 0.193±0.0299ab 0.106±0.0119b <0.001
ßPost hoc comparisons (Tukeys method) were used to further differentiate between the three groups, thus within rows values with different superscript letters differ at
P<0.01.
¥difference between weight at necropsy minus the gravid uterus, and weight at embryo transfer;
þchange in external body condition score (BCS) from embryo transfer to necropsy.
https://doi.org/10.1371/journal.pone.0228732.t001
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Table 2. Conceptus phenotype and adipose cell distribution in the fetal perirenal fat depot at 130 days of gestation in relation to maternal nutrition, prenatal
growth category and sex (Experiment 1). Values are group means ±sem.
Gestational intake Control Overnourished
Growth status Normal Non-Restricted Restricted P value¥
Fetal sex Female Male Female Male Female Male GI/growth Sex Interaction
Number 19 9 8 8 8 8
Gestational age, d 130.5±0.33 131.0±0.62 131.1±0.44 130.1±0.44 130.8±0.39 131.5±0.50 0.536 0.903 0.228
Fetal wt, g 4470±85b 5192±142a 4673±221ab 4701±226ab 2955±137c 3216±210c <0.001 0.015 0.082
Placentome wt, g 490±19ab 526±23a 411±27ab 434±34b 229±17c 270±25c <0.001 0.116 0.949
Fetal:placentome wt 9.27±0.26c 10.00±0.48bc 11.58±0.55ab 11.12±0.71abc 13.13±0.58a 12.29±0.96ab <0.001 0.681 0.308
Brain:liver wt 0.303±0.012c 0.285±0.013c 0.291±0.017c 0.336±0.021bc 0.461±0.024a 0.390±0.037ab <0.001 0.395 0.042
Fetal insulin, ng/ml 0.54±0.041 0.53±0.046 0.52±0.045 0.36±0.028 0.40±0.051 0.36±0.057 0.007 0.081 0.297
Perirenal fat wt, g 24.7±0.86a 22.04±0.95ab 21.33±1.21ab 21.93±1.75ab 17.01±1.32b 16.88±1.30b <0.001 0.474 0.346
Perirenal fat, g/kg fetus 5.56±0.22a 4.28±0.25b 4.56±0.169ab 4.66±0.30ab 5.82±0.46a 5.29±0.28ab 0.016 0.023 0.065
Unilocular fat
Volume density, % 40.6±1.45b� 41.0±1.97b� 43.7±2.50ab� 50.9±2.54a 42.3±1.79ab� 47.7±2.18ab 0.006 0.014 0.207
Total mass, g 10.0±0.50abɤ 9.1±0.73abɤ; 9.3±0.78abɤ; 11.3±1.27a 7.2±0.64bɤ; 8.1±0.78ab 0.007 0.311 0.151
Relative mass, g/kg fetus 2.26±0.12ß 1.78±0.17ß 1.99±0.12ß 2.40±0.23 2.47±0.22ß 2.52±0.17 0.029 0.970 0.038
Largest unilocular cell/image, pixcels 517±9.2 535±19.8 519±16.5 540±16.8 519±16.8 535±13.1 0.977 0.145 0.990
Multilocular fat
Volume density, % 59.4 ±1.45a� 59.0±1.97a� 56.3±2.50ab� 49.0±2.54b 57.7±1.79ab� 52.3±2.18ab 0.006 0.014 0.204
Total mass, g 14.7±0.63aɤ; 12.9±0.48abɤ; 12.0±0.83abcɤ; 10.6±0.78bc 9.8±0.78bcɤ; 8.8±0.71c <0.001 0.030 0.889
Relative mass, g/kg fetus 3.3±0.15aß 2.5±0.11cß 2.6±0.16bcß 2.3±0.15c 3.3±0.28abß 2.8±0.19abc 0.007 0.001 0.423
¥Post hoc comparisons (Tukey’s method) were used to further differentiate between the six groups, thus within rows values with different superscript letters differ at
P<0.05. Within individual groups adipose cell parameters with the same symbol (�,ɤ;, ß) differ from each other, P<0.05 to <0.001. Significant P values are highlighted
in bold. Gestational intake, GI
https://doi.org/10.1371/journal.pone.0228732.t002
Table 3. Fetal perirenal fat gene expression at 130 days of gestation in relation to maternal nutrition, prenatal growth category and sex (Experiment 1).
Gestational intake Control Overnourished
Growth status Normal Non-Restricted Restricted P value¥
Fetal sex Female Male Female Male Female Male GI/growth Sex Interaction
Number 19 9 8 8 8 8
18s 0.022±0.001 0.019±0.001 0.022±0.001 0.022±0.001 0.023±0.001 0.022±0.001 0.102 0.428 0.482
PPARɤ;:18s 11.68±0.594b 12.83±0.972ab 11.49±0.877ab 12.36±0.938ab 14.21±1.45ab 15.58±0.81a 0.007 0.152 0.970
G3PDH:18s 26.8±1.32c 29.31±2.71bc 30.73±1.53abc 26.34±1.90c 39.42±2.64a 36.83±1.83ab <0.001 0.377 0.185
LPL:18s 24.11±1.69 25.38±3.99 23.26±2.62 20.10±1.86 20.30±2.27 26.01±4.92 0.566 0.603 0.383
FASN:18s 18.41±1.50 21.45±3.92 16.81±2.38 19.80±2.77 12.65±2.08 21.25±5.93 0.381 0.155 0.572
HSL:18s 22.43±1.41b 27.13±2.69ab 29.54±3.29ab 28.03±2.06ab 31.87±3.18a 34.98±2.73a 0.003 0.221 0.448
Leptin:18s 24.84±1.64 20.42±1.19 27.04±2.03 21.20±2.04 27.47±2.66 24.11±2.02 0.297 0.010 0.854
Adiponectin:18s 19.39±1.17 18.54±2.19 19.87±1.94 16.90±1.87 18.64±2.04 20.70±2.20 0.812 0.705 0.455
IGF1:18s 20.65±2.27a 22.63±2.89a 16.74±0.95ab 21.29±2.58a 12.61±1.51b 19.52±2.74ab 0.034 0.009 0.348
IGF2:18s 21.82±1.36 24.46±3.57 20.81±2.04 22.43±1.10 18.41±1.83 22.76±3.04 0.527 0.127 0.826
IGF1R:18s 30.05±2.84 30.01±2.47 32.00±3.07 32.68±3.97 36.75±3.15 37.41±3.04 0.019 0.624. 0.903
IGF2R:18s 28.67±1.59 28.95±1.97 30.71±2.57 32.72±3.23 32.25±2.57 34.75±3.02 0.157 0.458 0.945
UCP1:18s 31.9±3.63b 35.55±4.04b 45.21±5.07b 34.59±6.53b 77.31±6.77a 49.02±4.30b <0.001 0.007 0.009
¥Post hoc comparisons (Tukeys method) were used to further differentiate between the six groups, thus within rows values with different superscript letters differ at
P<0.05. Significant P values are highlighted in bold. Gestational intake, GI
https://doi.org/10.1371/journal.pone.0228732.t003
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(ID) as a random factor. For the leptin profiles, concentrations measured serially from birth
were averaged between weeks 0–11, 12–22, 23–38, 40–64, 66–89 and 91–108 (n = 10–11 sam-
ples per age block) and prenatal growth status, sex and age were fixed-factors in the model
together with all potential interactions. For the NEFA and glycerol concentrations (average
fasting levels, slope and AUC after glucose bolus), each sex was examined separately, and pre-
natal growth-status and age were the fixed-factors. Post hoc comparison between groups at all
ages was by Fishers LSD method using the SED for comparison of means. Bone mineral density
and body fat percentage across the life-course were interrogated using regression analyses: the
mean slopes and intercepts and all offspring variables measured on a single occasion at nec-
ropsy were analyzed using one-way ANOVA for each sex separately, and by a GLM ANOVA
as detailed above to determine the effects of prenatal growth-status, sex, and their potential
interaction. Pearson product-moment correlation analysis was used to explore relationships
between variables where indicated and data are presented as correlation coefficients (r). Statisti-
cal significance was taken as P�0.05.
Results
Experiment 1 (fetal study): Maternal and fetal phenotype
By design the adolescent dams that received a control intake maintained their initial adipos-
ity score from embryo transfer until necropsy at day 130 of gestation (Table 1). By compari-
son the adiposity score of overnourished dams steadily increased and was equivalent to a
gain of 8% body fat by late gestation. Similarly, the overnourished dams had greater gesta-
tional weight gain and carcass weight at necropsy, and this anabolic state was reflected by
greater plasma insulin and glucose concentrations and attenuated plasma NEFA. Within the
overnourished pregnancies, maternal anthropometry and metabolic status was largely inde-
pendent of whether the fetus was classified as markedly growth-restricted or not: the excep-
tion was the maternal NEFA concentrations which were lower in the restricted compared
with the non-restricted pregnancies (P<0.05 by unpaired t-test). Irrespective of maternal
nutrition or growth category, male fetuses were slightly heavier than females (P = 0.015),
and by design growth-restricted fetuses of both sexes were lighter than the corresponding
sex of normally-growing control and non-restricted fetuses (32 to 38% lower, P<0.001,
Table 2). Relative to the normally-growing control group, average placentome weight was
reduced by ~50% in the restricted pregnancies (P<0.001) and although a greater fetal:pla-
cental weight ratio implies greater placental efficiency, the higher brain:liver weight ratio is
commensurate with brain sparing. Average placentome weight was ~16% lower in the non-
restricted overnourished pregnancies relative to the control group (P<0.05) but this degree
of placental growth-restriction was below the estimated functional reserve capacity of the
ovine placenta [42] and did not impact fetal weight per se. Fetal plasma insulin concentra-
tions were normal>non-restricted>restricted for females and males combined, (P = 0.006
by one way ANOVA, normal versus restricted, P<0.05 post hoc).
Fetal adiposity
Absolute PAT mass was positively correlated with fetal weight (r = 0.559, n = 60, P<0.001) and
accordingly was lowest in growth-restricted fetuses (restricted<normal = non-restricted for
females and males combined, P<0.01 post hoc). When expressed relative to fetal weight, PAT
mass was influenced by both maternal nutrition/growth category (restricted>normal>non-
restricted, P = 0.016) and fetal sex (female>male, P = 0.023, Table 2): the effect of sex was
most pronounced in the normally-growing fetuses. Absolute unilocular cell mass was lower in
the restricted fetuses (restricted<control = non-restricted for females and males combined,
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P<0.05 post hoc) but not when expressed relative to fetal weight. Similarly, absolute multilocu-
lar cell mass was influenced by maternal nutrition/growth category (restricted<non-restric-
ted<normal, P<0.001) and fetal sex (females>males, P = 0.030). When multilocular cell
mass was expressed relative to fetal weight the effect of growth category was largely reversed
(restricted = normal>non-restricted, P = 0.007) and the impact of sex maintained (fema-
les>males, P = 0.001). All three groups of female fetuses and the control males had a higher
relative proportion (volume density) of multilocular compared with unilocular cells (P<0.05
to<0.001) and accordingly a higher absolute and fetal weight-specific multilocular cell mass.
Maternal NEFA concentrations at necropsy were positively correlated with multilocular fat
cell mass in both female and male fetuses (r = 0.684, n = 35, and r = 0.624, n = 25, respectively,
both P<0.001, Fig 1a) while an inverse association was detected between maternal insulin con-
centrations and the multilocular fat component (females r = -0.629, P<0.001; males r = -0.501,
P = 0.011). None of the indices of maternal metabolic status were related to the unilocular fat
cell mass (P>0.1). Placental mass was positively associated with both multilocular and unilocu-
lar fat cell mass in female fetuses (r = 0.629 and r = 0.632 P<0.001) and with multilocular but
not unilocular fat mass in males (r = 0.547, P = 0.005 and r = 0.294, P>0.1). The relationship
between the mass of the placenta and the multilocular fat in both sexes is shown in Fig 1b.
Fetal PAT gene expression
Growth-restricted fetuses had higher relative abundance of PPARɤ;, G3PDH, HSL and IGF1-R
mRNA in their PAT than both normal and non-restricted fetuses which were similar to each
other (P = 0.007, P<0.001, P = 0.003 and P = 0.019, respectively, Table 3). Consequently, these
genes were negatively associated to varying degrees with maternal NEFA concentrations, feto-
placental weights, absolute PAT mass and the multilocular fat component (Table 4). Positive
relationships between maternal insulin concentration and both HSL and IGF1-R mRNA were
also evident. The inverse relationship between placental weight and PAT G3PDH mRNA
expression was pronounced and evident in both female and male fetuses (r = -0.704, P<0.001
and r = -0.562, P = 0.003, Fig 1c). A similar relationship between placentome weight and UCP-
1 mRNA expression was evident (r = -0.728, P<0.001 and r = -0.495, P = 0.012 for females
and males, respectively, Fig 1d): the two factor ANOVA confirmed increased abundance of
UCP-1 in restricted fetuses (P<0.001) and the significant growth status x gender interaction
(P = 0.009) reflected particularly high expression in growth-restricted females (Table 3). UCP-
1 expression was weakly positively associated with maternal insulin and glucose, and inversely
associated with maternal NEFA, absolute fat mass and both the unilocular and multilocular
components (Table 4). PAT leptin mRNA was independent of growth status, but females had
higher expression than males (Table 3, P = 0.01), commensurate with their greater adiposity.
Fetal sex was also the dominant influence on PAT IGF1 mRNA but in this instance, males
had higher expression than females (P = 0.009). LPL, FASN, Adiponectin, IGF2 and IGF2-R
mRNA levels were independent of growth-status and sex but positive relationships between
fetal insulin and PAT LPL and FASN abundance were evident for the study population overall
(Table 4) and separately in females (r = 0.468, P = 0.005 and r = 0.445, P = 0.007) and males
(r = 0.452, P = 0.027 and r = 0.483, P = 0.017, Fig 1e and 1f).
Experiment 2 (postnatal study): Phenotype at birth and mid-adulthood
Details of pregnancy outcome and offspring growth, glucose metabolism and body composi-
tion at key stages from infancy to mid-adulthood have been presented elsewhere [35]. Of 49
offspring entering the study, 44 completed it and are the focus here. Relative to the normally-
growing controls, growth-restricted lambs from overnourished dams were born on average 4
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Fig 1. Indices of nutrient supply associated with fetal fat phenotype and gene expression. Relationships between (a)
maternal plasma NEFA concentration and fetal multilocular fat cell mass, (b) placentome weight and multilocular fat
cell mass, (c) placentome weight and fetal perirenal adipose tissue (PAT) G3PDH mRNA, (d) placentome weight and
PAT UCP-1 mRNA, (e) fetal plasma insulin concentration and PAT LPL mRNA and (f) fetal plasma insulin and PAT
FASN mRNA at day 130 of gestation. For female (open circles) and male (closed circles) fetuses respectively in (a)
r = 0.684, P<0.001 and r = 0.624, P = 0.001; in (b) r = 0.629, P<0.001 and r = 0.547, P = 0.005; in (c) r = -0.704,
P<0.001 and r = -0.562, P = 0.003; in (d) r = -0.728, P<0.001 and r = -0.495, P = 0.012; in (e) r = 0.468, P = 0.005 and
r = 0.452, P = 0.027; in (f) r = 0.445, P = 0.007 and r = 0.483, P = 0.017.
https://doi.org/10.1371/journal.pone.0228732.g001
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days earlier (mean±sem: 143.8±0.27 versus 139.8±0.42 days), were ~42% lighter at birth (5578
±141 versus 3234±167g, Table 5), had a smaller girth at the umbilicus (40.4±0.51 versus 34.2
±0.71cm), and a reduced height at the shoulder (34.0±0.40 versus 27.4±0.76cm). This reduced
prenatal growth reflected a 43% decrease in fetal placental weight (523±29 versus 297±20g)
and all these measures of size at birth were statistically significant (P<0.001) and independent
of offspring sex.
Plasma leptin and offspring adiposity
Weekly changes in peripheral plasma leptin concentrations during the suckling phase and con-
centrations averaged during defined ages thereafter are shown in Fig 2a and 2b. Neither prena-
tal growth status nor sex influenced leptin concentrations at birth or 1 week of age; thereafter
levels diverged with females greater than males throughout the rest of the suckling period
(P<0.001). Indeed, female offspring had persistently higher leptin concentrations than males
throughout the life-course (P<0.001). In both sexes average leptin secretion increased between
the 12 to 22, and, 23 to 38 weeks of age periods: maximum concentrations in females were
reached between 66 and 89 weeks and plateaued thereafter, whereas in males the maximum
levels observed were between weeks 91 and 108 of age. Although the repeated measures analy-
sis did not detect an influence of prenatal growth category overall, there was a prenatal growth
� age interaction (P = 0.042) with post hoc analysis indicating that growth-restricted males had
a trend for higher leptin concentrations than normal males from adolescence forwards. Irre-
spective of prenatal growth status and sex, average peripheral leptin concentrations in the age
period preceding DEXA assessment were positively associated with percentage body fat at 11,
41 and 64 weeks (Fig 2c, 2d and 2e, P<0.001) but by 107 weeks the relationship was no longer
significant (Fig 2f, P>0.08). Similarly, plasma leptin concentrations immediately pre-necropsy
were equivalent between the four groups. In contrast there was a trend for lower plasma adipo-
nectin concentrations pre-necropsy in growth-restricted versus normal birthweight males
(P = 0.053) and the plasma adiponectin: leptin ratio, a putative marker of insulin resistance
[43], was reduced (P = 0.04) in the former group. Birth weight and plasma adiponectin at nec-
ropsy was positively associated in males (r = 0.496, P = 0.036) but not females.
Table 4. Relationship between perirenal fat gene expression (relative to 18S) and maternal metabolic status, fetal plasma insulin, conceptus mass and fat mass at
day 130 of gestation, irrespective of maternal nutrition, prenatal growth category and sex (Experiment 1).
PPARɤ; G3PDH LPL FASN HSL Leptin Adiponectin IGF1 IGF2 IGF1-R IGF2-R UCP1
Maternal glucose 0.239 0.190 0.097 0.094 0.176 -0.131 -0.192 0.108 0.171 0.277� 0.247 0.290�
Maternal NEFA -0.337�� -0.324� -0.201 -0.097 -0.469��� -0.024 0.100 -0.003 -0.148 -0.366�� -0.346�� -0.330��
Maternal insulin 0.180 0.264� -0.064 -0.078 0.435��� 0.060 0.128 -0.179 -0.104 0.303�� 0.408�� 0.322�
Placentome wt, g -0.335�� -0.644��� 0.233 0.258� -0.416��� -0.170 -0.061 0.306� 0.241 -0.212 -0.197 -0.633���
Fetal wt, g -0.297� -0.505��� 0.052 0.093 -0.329�� -0.198 -0.086 0.297� 0.179 -0.155 -0.157 -0.451���
Fetal insulin -0.046 -0.289� 0.410��� 0.346�� -0.180 0.256 0.012 0.233 0.239 -0.144 -0.098 -0.181
Perirenal fat g -0.347�� -0.480��� -0.009 0.015 -0.404�� 0.106 0.123 -0.011 -0.078 -0.441��� -0.366�� -0.434���
Unilocular fat mass, g -0.144 -0.344�� 0.050 0.125 -0.190 0.090 0.115 0.017 0.059 -0.210 -0.117 -0.335��
Multilocular fat mass, g -0.404�� -0.439�� -0.056 -0.081 -0.453��� 0.086 0.089 -0.032 -0.166 -0.491��� -0.411�� -0.376��
Significant r values highlighted in bold
�P<0.05,
��P<0.01,
���P<0.001.
https://doi.org/10.1371/journal.pone.0228732.t004
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NEFA and glycerol: Fasting concentrations and metabolism during glucose
tolerance tests
Summary NEFA and glycerol concentrations in the fasted state and following glucose challenge
at 7, 32, 60, 85 and 106 weeks of age in relation to prenatal growth status and sex are presented
in Table 6, and the latter acted as a proxy measure of insulin-induced adipose tissue lipid metab-
olism. NEFA and glycerol profiles following the glucose challenge close to study end are shown
in Fig 3a and 3b. The mixed-method repeated-measures analysis approach indicates that over
the five life-stages, fasting NEFA concentrations were significantly influenced by prenatal
Table 5. Phenotype, plasma adipokines and perirenal fat gene expression at necropsy in mid-adult life in relation to gestational intake, prenatal growth status and
sex (Experiment 2).
Gestational intake Control Overnourished Control Overnourished P value glm
Prenatal growth status Normal Restricted Normal Restricted Prenatal growth
status
Sex Interaction
Gender Female,
n = 10
Female, n = 16 NF vs RF Male, n = 11 Male, n = 7 NM vs
RM
Reference birth weight, g 5287±251a 3361±201b <0.001 5843±98a 2943±287b <0.001 <0.001 0.634 0.027
Age at necropsy, d 768±0.8a 767±0.7a 0.373 774±0.4b 773±0.8b 0.150 0.128 <0.001 0.848
Live weight (LW), kg 109.5±1.62a 104.92±2.64a 0.256 147.3±1.31b 137.9±4.67b 0.033 0.014 <0.001 0.387
¥Bone mineral density, g/cm 1.026±0.018a 0.968±0.014a 0.018 1.373±0.027b 1.259±0.057c 0.061 0.003 <0.001 0.306
¥Body fat % 44.10±1.209a 52.02±1.078b 0.001 43.72±0.941a 46.19±0.832a 0.088 <0.001 0.010 0.023
¥Fat:lean mass 0.841±0.045b 1.142±0.056a 0.001 0.821±0.035b 0.902±0.031b 0.128 0.001 0.016 0.040
Bone mineral density vs age
Average slope, g/cm per
week
0.0043
±0.0003a
0.0043±0.0002a 0.924 0.0081
±0.0003b
0.0073±0.0005b 0.205 0.191 <0.001 0.224
Average intercept, g/cm 0.611±0.016a 0.546±0.014b 0.006 0.576±0.015ab 0.536±0.020b 0.121 0.003 0.179 0.452
Body fat % vs age
Average slope, % per week 0.2282
±0.0146a
0.2837±0.0151b 0.020 0.2931
±0.0135b
0.2776
±0.0118ab
0.434 0.210 0.069 0.029
Average intercept, % 21.16±0.826a 21.77±1.180a 0.712 11.36±0.916b 14.12±1.180b 0.081 0.155 <0.001 0.362
Perirenal fat mass, g 1713±232a 2489±176c 0.014 3453±221b 2797±210bc 0.061 0.785 <0.001 0.002
Perirenal fat mass, g/kg LW 15.5±2.04a 23.7±1.73b 0.007 23.4±1.47b 20.2±1.23ab 0.146 0.185 0.232 0.004
Plasma leptin, ng/ml 25.3±1.20 28.1±1.64 0.247 23.8±2.07 26.0±0.46 0.417 0.167 0.314 0.878
Plasma adiponectin, μg/ml 4.20±0.190 4.66±0.267 0.241 4.61±0.275 3.78±0.239 0.053 0.506 0.400 0.026
Plasma adiponectin: leptin 172±9.1 182±19.3 0.689 206±20.1 146±10.9 0.040 0.965 0.200 0.072
18s 0.035±0.003 0.033±0.001 0.314 0.033±0.002 0.033±0.002 0.962 0.495 0.907 0.544
PPARɤ;:18s 17.40±1.30c 23.0±1.29bc 0.009 29.14±2.12ab 30.91±2.81a 0.617 0.057 <0.001 0.314
G3PDH:18s 29.02±2.28a 28.22±2.20a 0.815 22.72±1.62ab 17.97±1.41b 0.059 0.212 0.001 0.370
LPL:18s 15.878
±0.732a
17.924±0.994ab 0.161 20.519
±0.877b
20.164±1.580ab 0.834 0.441 0.003 0.276
FASN:18s 11.03±1.99c 14.17±1.71bc 0.257 21.3±2.51ab 25.25±4.24a 0.403 0.168 <0.001 0.873
HSL:18s 10.53±1.33c 19.14±2.12bc 0.008 38.21±5.62a 32.19±2.17ab 0.416 0.730 <0.001 0.047
Leptin:18s 12.124
±1.874a
19.484±1.785ab 0.013 24.297
±3.038b
26.398±2.637b 0.637 0.062 <0.001 0.293
Adiponectin:18s 10.378
±1.510a
15.476±1.340a 0.023 26.989
±2.801b
24.029±2.121b 0.461 0.610 <0.001 0.060
IGF1:18s 26.76±2.37 25.34±1.96 0.653 27.52±1.98 22.25±1.43 0.074 0.130 0.594 0.380
IGF2:18s 27.65±4.12 25.62±4.12 0.645 20.82±2.18 17.43±2.08 0.306 0.350 0.013 0.814
INSR:18s 17.046±1.060 19.457±0.768 0.074 17.722±1.192 19.632±1.486 0.332 0.059 0.703 0.822
¥By DEXA at 107 weeks. Normal female (NF), restricted female (RF), normal male (NM), restricted male (RM)
https://doi.org/10.1371/journal.pone.0228732.t005
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growth-status and postnatal age in both sexes with post hoc analysis revealing markedly higher
levels in restricted compared with normal females at 32, 60 and 106 weeks, and in restricted
versus normal males at 32 and106 weeks. Irrespective of prenatal growth category, males had
higher fasting NEFA concentrations than females at 7, 32 and 60 weeks but by study end the
sexes were equivalent. NEFA concentrations increased transiently after glucose administration
before falling sharply in response to the associated increase in insulin (see [35] for insulin pro-
files) and concentrations did not return to baseline within the sampling period at the 60, 85 or
106 week-challenges. The insulin-induced fall in NEFA output during the glucose tolerance test
was reduced in growth-restricted versus normal offspring of both sexes, resulting in a higher
NEFA AUC: the post hoc analysis indicated that the most pronounced differences were at 32, 60
and 106 weeks in females and at 7, 32, 60 and 106 weeks in males. These differences were largely
independent of any change in slope from 10 to 30 minutes after glucose bolus. Birthweight was
inversely correlated with fractional growth rate (FGR) for weight during the suckling phase (D0-
77) in both sexes (females r = -0.898, P<0.001; males r = -0.924, P<0.001) and strong associa-
tions between birthweight, early relative growth and NEFA concentrations were evident close to
study end. Thus, baseline and AUC NEFA decreased with increasing birthweight in both sexes
(Fig 3c and 3e) while baseline (not shown) and AUC NEFA at 106 weeks of age were positively
associated with FGR during early postnatal life (Fig 3f). In contrast there was no relationship
Fig 2. Circulating leptin and body fat percentage across the life-course. Effect of prenatal growth-restriction and sex on peripheral plasma leptin
concentrations from birth to weaning at 11 weeks of age (a) and on average leptin concentrations during defined periods throughout the life-course (b) in
offspring that completed the study (n = 44). Relationship between average leptin concentrations (mean of 10–11 samples) between age 0 to 11(c), 23 to 38 (d), 40
to 64 (e) and 91 to 108 (f) weeks and body fat percentage measured by DEXA at 11, 41, 64 and 107 weeks of age. Normal birthweight females are denoted by open
bars or circles; growth-restricted females by checked bars or circles; normal males by black bars or circles and growth-restricted males by grey bars or circles. In
(b) leptin concentrations were influenced by age and sex and there was a significant prenatal growth � age interaction. Post hoc comparisons were used to further
differentiate between the four groups across the life-course and bars with different superscript letters differ at P<0.05. Irrespective of prenatal growth category
and gender in (c) r = 0.592, P<0.001; in (d) r = 0.732, P<0.001; in (e) r = 0.683, P<0.001 and in (f) r = 0.260, P = 0.088, not significant.
https://doi.org/10.1371/journal.pone.0228732.g002
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Table 6. NEFA and glycerol concentrations in the fasted state and following glucose challenge at 7, 32, 60, 85 and 106 weeks of age in relation to gestational intake,
prenatal growth status and sex (Experiment 2).
Gestational intake Control Overnourished P value (glm)
Prenatal growth status Normal Restricted Normal Restricted Prenatal growth
status
Sex Interaction
Gender Female, n = 10 Female, n = 16 Male, n = 11 Male, n = 7
Fasting NEFA, mmol/l
- 7 weeks 0.179±0.013f 0.211±0.030f 0.201±0.030f 0.362±0.070ef 0.012 0.023 0.086
- 32 weeks 0.789±0.058bc 1.064±0.072a 1.025
±0.081bc
1.314±0.069a 0.001 0.004 0.926
- 60 weeks 0.696±0.028cd 0.863±0.048b 0.910
±0.084bc
1.062±0.084b 0.019 0.003 0.912
- 85 weeks 0.487±0.049e 0.605±0.041de 0.404±0.040e 0.447
±0.054de
0.101 0.016 0.444
- 106 weeks 0.556±0.039e 0.861±0.053b 0.622±0.046d 0.860±0.100c <0.001 0.602 0.584
¥RM P value - growth status <0.001 0.016
- age <0.001 <0.001
- growth status x age 0.020 0.281
NEFA slope, 10 to 30min after glucose (μmol/l per
min)
- 7 weeks -3.7±0.98a -4.75±1.18a -6.0±2.16a -9.8±2.17a 0.252 0.080 0.522
- 32 weeks -23.7±3.0d -34.1±2.45e -29.6±4.1c -30.0±5.86c 0.153 0.817 0.185
- 60 weeks -13.2±0.94bc -19.7±1.81cd -19.0±1.48b -19.2±4.53b 0.141 0.234 0.154
- 85 weeks -13.3±1.55bc -11.6±1.51b -12.5±1.53ab -8.0±1.71a 0.075 0.201 0.412
- 106 weeks -14.5±5.76bc -8.80±2.84ab -12.5±2.38ab -9.3±2.17a 0.227 0.829 0.727
¥RM P value - growth status 0.285 0.786
- age <0.001 <0.001
- growth status x age 0.005 0.660
NEFA AUC (mmol/l x min)
- 7 weeks 11.93±0.936f 14.01±1.80ef 12.84±2.49ef 23.34±5.02bcd 0.017 0.050 0.104
- 32 weeks 19.55±2.04cd 28.71±2.02a 23.26±1.66bc 32.30±4.84a 0.001 0.161 0.982
- 60 weeks 14.29±0.910ef 23.56±1.382bc 16.30±1.34de 34.7±6.78a <0.001 0.015 0.084
- 85 weeks 15.30±1.28def 17.11±1.54de 9.84±1.28f 13.78±3.11ef 0.117 0.019 0.557
- 106 weeks 18.86±1.90cde 26.70±1.77ab 18.42±2.18cde 27.84±3.20ab <0.001 0.877 0.727
¥RM P value - growth status <0.001 0.006
- age <0.001 <0.001
- growth status x age 0.049 0.063
Fasting glycerol, μmol/l
- 7 weeks 61.5±3.33f 80.2±8.86def 63.5±6.28de 75.4±8.21cd 0.061 0.863 0.668
- 32 weeks 97.4±8.95bcd 128.7±8.12a 103.0±5.67b 126.7±9.71a 0.003 0.835 0.663
- 60 weeks 93.9±7.55cde 107.6±5.85bc 91.9±7.60bc 109.5
±10.51ab
0.050 0.994 0.801
- 85 weeks 71.6±3.79ef 84.7±8.45def 52.3±4.37e 59.1±4.32de 0.177 0.004 0.664
- 106 weeks 109.5±6.49abc 117.7±11.2ab 69.4±3.26d 91.5±7.44bc 0.118 0.001 0.465
¥RM P value - growth status 0.031 0.011
- age <0.001 <0.001
- growth status x age 0.582 0.628
Glycerol slope, 10-30min after glucose (μmol/l per
min)
- 7 weeks -1.03±0.331a -1.46±0.333a -0.88±0.236a -1.19±0.468a 0.305 0.552 0.854
- 32 weeks -1.62±0.296ab -2.94±0.561bc -1.22±0.305a -1.76±0.435a 0.071 0.128 0.444
- 60 weeks -1.35±0.194a -3.06±0.335c -1.67±0.190a -3.54±0.596b <0.001 0.255 0.824
(Continued)
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between current liveweight at 106 weeks and the NEFA response to glucose challenge in either
sex (r = -0.220, P>0.3 and r = -0.205, P>0.4).
Fasting glycerol concentrations were also moderately impacted by prenatal growth cate-
gory. Relative to the normally growing comparators the most distinct elevations in fasting con-
centrations were detected at 32 and 106 weeks in restricted males and at 32 weeks in restricted
females. However, the GLM approach indicates that offspring sex is the dominant influence
during the second year of life with females having higher concentrations than males at 85 and
106 weeks, reflecting their greater adiposity. Following glucose administration, the fall in glyc-
erol concentrations (slope) was modestly influenced by prenatal growth category in both sexes
and was particularly steep in growth-restricted females at 60 and 95 weeks, and in growth-
restricted males at 60 weeks of age. As above the reduced insulin sensitivity during the glucose
tolerance test as a whole resulted in a higher AUC glycerol in growth-restricted versus normal
offspring of both sexes with the most distinct differences observed at challenges carried out
between 7 and 60 weeks of age. Offspring sex (female>male) was the overriding influence on
AUC glycerol at 85 and 106 weeks. Irrespective of prenatal growth status or sex, circulating
NEFA and glycerol concentrations (fasting and post-glucose challenge) were positively associ-
ated at all 5 life stages (ranging from r = 0.471 to 0.801, P = 0.002 to<0.001). Close to study
end birthweight was inversely associated with fasting glycerol concentrations in males but not
females (Fig 3d).
Offspring phenotype in relation to PAT gene expression at necropsy
As reported previously [35] and included here for comparative purposes bone mineral den-
sity and live weight at study end in mid-adult life were influenced by prenatal growth-status
(restricted< normal) and gender (females <males, Table 5), while in contrast percentage
body fat and fat:lean mass were greater in growth-restricted offspring and in females com-
pared with males, predominately due to higher adiposity in the growth-restricted female
Table 6. (Continued)
Gestational intake Control Overnourished P value (glm)
Prenatal growth status Normal Restricted Normal Restricted Prenatal growth
status
Sex Interaction
Gender Female, n = 10 Female, n = 16 Male, n = 11 Male, n = 7
- 85 weeks -2.26±0.473ab -3.03±0.477c -1.03±0.374a -1.69±0.407a 0.155 0.013 0.906
- 106 weeks -2.97±1.05bc -3.43±0.376c -3.25±0.531b -3.60±0.594b 0.541 0.730 0.931
¥RM P value - growth status 0.027 0.021
- age 0.001 <0.001
- growth status x age 0.510 0.300
Glycerol AUC (μmol/l x min)
- 7 weeks 4255±331bc 5390±508a 4176±412b 5098±658a 0.050 0.717 0.836
- 32 weeks 2432±233e 3654±260cd 2576±194cde 3209±351c 0.002 0.588 0.290
- 60 weeks 2588±253e 3235±320de 1860±110ef 3026±462c 0.007 0.148 0.419
- 85 weeks 2724±257de 3102±234de 1738±163f 2070±203def 0.151 <0.001 0.926
- 106 weeks 4873±379ab 4514±300b 2577±205cde 2856±212cd 0.898 <0.001 0.312
¥RM P value - growth status 0.034 0.008
- age <0.001 <0.001
- growth status x age 0.093 0.545
¥Repeated measures ANOVA carried out separately for females and males, with post hoc comparisons using Fisher’s LSD method. Values with a different superscript
letter differ <0.05. Significant P values are highlighted in bold.
https://doi.org/10.1371/journal.pone.0228732.t006
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Fig 3. Lipid metabolism in mid-adult life in relation to early growth trajectories and sex. Plasma concentrations of
NEFA (a) and glycerol (b) following bolus administration of glucose at 106 weeks of age in normal (open circle) and
prenatally growth-restricted (checked circle) females, and normal (black circle) and growth- restricted (grey circle)
males. Values are mean ± sem. Relationship between birthweight and fasting concentrations of NEFA (c) and fasting
glycerol (d) at 106 weeks of age, and relationship between birthweight (e) and fractional growth rate (FGR) from birth
to weaning (f) and NEFA AUC at 106 weeks of age. For female (open circles) and male (solid circles) offspring
respectively in (c) r = -0.756, P<0.001 and r = -0.500, P = 0.034; in (d) r = -0.234, P>0.2 and r = -0.548, P = 0.019; in
(e) r = -0.726, P<0.001 and r = -0.611, P = 0.007; in (f) r = 0.712, P<0.001 and r = 0.577, P = 0.016.
https://doi.org/10.1371/journal.pone.0228732.g003
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group. Herein we have additionally used regression analysis of the serial DEXA data to esti-
mate body composition at birth (0 weeks, intercept) and the average change across the life-
course thereafter (slope). Individual regression analysis of bone mineral density against age
revealed that the average slope of the regression lines was ~80% steeper in males than in
females (P<0.001), independent of prenatal growth. Conversely the mean intercept (esti-
mated BMD at birth) was ~9% lower in growth-restricted compared with normal groups
(P = 0.003), irrespective of sex. A prenatal growth x sex interaction (P = 0.029) was evident
for the average slope of the individual regression lines of body fat percentage against age.
This reflected both a relatively higher rate of body fat accrual in (a) normal males versus
normal females, and in (b) growth-restricted females versus normal females (28 and 24%,
respectively, both P<0.05, from post hoc analysis). In contrast the mean intercept (estimated
body fat % at birth) was ~ 73% higher in females than males (P<0.001), irrespective of pre-
natal growth category. DEXA is considered the gold standard for assessing body composi-
tion and the average slopes of the individual regression lines for fat accrual across the life
course were wholly mirrored by corresponding differences in absolute and live weight-spe-
cific perirenal adipose tissue mass at necropsy. A prenatal growth x sex interaction in abso-
lute and relative PAT mass was again evident (P = 0.002 and P = 0.004, respectively) and on
a live-weight specific basis reflected more renal fat in normal males versus normal females
(51%), and in growth-restricted females versus normal females (53%). Moreover, the indi-
vidual slopes of the regression lines for fat % against age were positively associated with
absolute and relative PAT mass for the population overall (r = 0.728 and 0.630, P<0.001)
and in females (r = 0.775 and 0.791, P<0.001) but not males (P>0.1) separately.
Offspring sex was the dominant influence on PAT gene expression per unit tissue at nec-
ropsy with the abundance of PPARɤ;, LPL, FASN, HSL, leptin and adiponectin mRNA being
robustly greater, and G3PDH and IGF2 mRNA lower in males compared with females
(P = 0.013 to <0.001, Table 5). When the sexes were considered separately none of the PAT
genes were differentially expressed in normal versus growth-restricted male offspring. How-
ever, growth-restricted females were characterised by higher abundance of PPARɤ;, HSL,
leptin and adiponectin mRNA than normal females (P = 0.023 to P = 0.009) in keeping with
their greater relative adiposity at study end.
Discussion
These studies in a robust and highly controlled model of prenatal growth-restriction demon-
strate that impaired fetal nutrient supply and sex both influence prenatal adipose tissue devel-
opment and selected gene expression with consequences for lipid metabolism and body
composition persisting into adult life.
Fetal growth, adiposity and perirenal fat gene expression
In the prenatal study, comparing growth-restricted and non-restricted fetuses gestated by over-
nourished adolescent dams with the normally growing controls allowed us to differentiate
between maternal nutrition and placental nutrient supply. It is clear that when placental size
was impaired beyond its functional reserve capacity in rapidly growing overnourished dams
that the resulting reduction in placental nutrient transport limited growth of the fetal body,
total perirenal fat deposition, and mass of its unilocular and multilocular components. How-
ever, when expressed relative to fetal weight, the mass of this dominant prenatal fat depot,
and in particular the proportion of multilocular adipocytes, was increased. Similarly, the
expression of UCP1, a key marker of brown adipose tissue functionality, was enhanced. These
in utero adaptations in nutrient partitioning priorities are likely to be beneficial to neonatal
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thermogenesis and survival since these small fetuses have a relatively high surface area to vol-
ume ratio making them particularly vulnerable to hypothermia, and they are also destined to be
born prematurely. Indeed, the up-regulated UCP1 expression is commensurate with an early
preparation for thermogenesis [11] and anecdotally these growth-restricted fetuses which are
viable following spontaneous delivery at day 135 of gestation onwards exhibit normal vigour
immediately after birth, suggesting that thermogenesis is largely unperturbed. The mechanistic
basis of the increase in relative adiposity in late gestation may begin earlier in pregnancy during
the proliferative phase of adipocyte development when both maternal and fetal glucose concen-
trations in overnourished dams are high, and before placental size per se is constrained [44].
Although direct evidence to support such a hypothesis in the present overnourished model is
not available, we have previously shown that the lean fetal phenotype that characterises the con-
trasting undernourished model emerges at mid-gestation when the expression of genes involved
in adipose tissue proliferation and differentiation, namely PPARɤ;, IGF1, IGF2 and their recep-
tors, were already attenuated by maternal undernutrition and the associated low glucose supply
[22]. In addition to glucose, evidence is beginning to accumulate that maternal lipids (triglycer-
ides and free fatty acids) are important substrates for fetal fat accretion and neonatal adiposity
in human pregnancies characterised by nutrient excess at conception and fetal overgrowth [45–
47]. At first glance a positive correlation between circulating maternal NEFA concentrations
and fetal multilocular cell mass in the present study appears to support this concept of ‘making
fat from fat’ but no relationship was evident between maternal NEFA and unilocular (fat stor-
age) cell mass. However, in contrast to the aforementioned humans with pre-pregnancy obe-
sity, the overnourished adolescent sheep mothers are anabolic throughout, and continue to
grow and progressively accrue body fat as pregnancy advances. Thus, circulating fatty acid con-
centrations remain low throughout gestation [36], particularly in the dams gestating the most
growth-restricted fetuses with the relatively fat phenotype (present study).
Irrespective of substrate, the relatively fat phenotype of the fetuses defined as growth-
restricted by late gestation was associated with greater adipose tissue expression of the primary
driver of adipogenesis, namely PPARɤ;, and specific genes involved in lipogenesis and fat
metabolism, namely G3PDH and HSL, respectively. The negative association between placental
size and the expression of these three genes, in addition to UCP1, implies they are a sensitive
barometer of impaired fetal nutrient supply and play a role in helping the growth-restricted
fetus adapt in preparation for the energetic demands of extrauterine life. This contrasts some-
what with prior data in adult sheep pregnancies demonstrating a link between a nutritionally-
mediated increase in maternal and hence fetal glucose during late gestation and greater fetal
PAT PPARɤ; gene expression, albeit independent of any change in fetal weight or adipose tis-
sue mass [17]. In the latter study, expression of other lipogenic (LPL) and adipokine (adipo-
nectin and leptin) genes were also greater in the overfed group, and this was replicated for LPL
and adiponectin by intrafetal administration of the PPARɤ; agonist, rosiglitazone [48]. This led
these researchers to suggest that precocial activation of these genes, with increased PPARɤ; as
the initiating mechanism prenatally, could underlie the increased subcutaneous adiposity
observed separately in the offspring of overfed dams at 30 days postnatal [49]. While we did
detect the expected positive relationship between fetal insulin concentrations and both LPL
and FASN abundance in PAT for the population as a whole herein, the expression of LPL,
FASN, adiponectin and leptin were independent of maternal nutrition and/or fetal growth cat-
egory, and only leptin mRNA was marginally positively related to fetal fat status.
Assessing prenatal fat status in analogous growth-restricted human fetuses in utero is tech-
nically challenging [50] and there is a paucity of information expressing any index of fat status
on a fetal weight or birthweight specific basis. Yajnik [51] postulated that the higher relative
adiposity observed in small and otherwise thin Indian babies (based on skinfold thickness) is
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an adaptation directed at preserving growth of the predominantly lipid-containing fetal brain,
with clear advantages for optimizing survival neonatally. The higher brain:liver weight ratio
observed in the relatively fat and growth-restricted ovine fetuses here supports this hypothesis.
Prenatal growth-restriction and postnatal lipid metabolism
The consequences of an altered prenatal growth trajectory, and the associated adaptations in
adipose tissue development for lipid metabolism and body composition postnatally, were eval-
uated in contemporaneously treated offspring. Rather than reporting a snapshot at a single age,
serial measures in the present study allowed a robust assessment across the life-course. Accord-
ingly, relative to normally-grown controls, the growth-restricted offspring gestated by over-
nourished dams had evidence of reduced insulin sensitivity in adipose tissue, namely higher
fasting NEFA concentrations and attenuated insulin-induced inhibition of lipolysis during a
glucose tolerance test (higher AUC NEFA), emerging while the lambs were rapidly growing
and still suckling at 7 weeks of age, and, becoming highly pronounced by adolescent life.
Although the magnitude of the differences between growth-restricted and normal offspring at
each age varied slightly by gender, ultimately this altered lipid metabolism persisted to mid-
adulthood in both sexes. At this stage, relative to normal females, the growth-restricted females
were fatter (rate of fat accrual and body fat % from DEXA), had a greater relative PAT mass
and higher expression of selected molecular markers of adipocyte function (discussed below).
By contrast male offspring still had the potential to accumulate further body fat and although
there was a trend for higher plasma leptin concentrations in growth-restricted males from ado-
lescence forwards they were not markedly fatter than normal males by mid-adult life. Further-
more, we failed to observe any prenatal growth-related change in the expression of genes
involved in adipocyte proliferation or function in adult males at study end. Nevertheless, given
the evidence of insulin resistance at this stage (higher NEFA AUC and lower plasma adiponec-
tin: leptin ratio), and our previously reported glucose intolerance from adolescence forwards in
the same cohort (higher glucose AUC after glucose bolus, [35]), it is probable that these males
would become obese in the longer term. Similar alterations in lipid metabolism during a glu-
cose tolerance test have been reported at 2.5 years (but not 1.5years) in ovine offspring of both
sexes following a short exposure to severe undernutrition during the first month of gestation
[52]. The latter exposure had no effect on birth weight in either sex [53] and it is intriguing that
models targeting such different periods of gestation, and with a contrasting influence on fetal
growth, have a similar metabolic phenotype in the adult offspring. Nonetheless, in the human
literature it is prenatal growth-restriction leading to low birthweight, as modelled here, that
most consistently relates to an increased risk of insulin resistance, type 2 diabetes and greater
adiposity at stages across the life-course, particularly when postnatal nutrient supply is abun-
dant [54–62]: in adults these conditions are all typified by higher fasting and postprandial
NEFA concentrations [63–65], with raised levels considered an early indicator of disease pro-
gression. In our animal model, plasma insulin concentrations (fasting and glucose-stimulated)
were initially greater in restricted compared with normal birthweight lambs during the suckling
and adolescent life stages, but there was no evidence of a primary β-cell deficiency in terms of
insulin secretion by study-end in mid-adult life [35]. Thus, the higher NEFA concentrations in
prenatally growth-restricted offspring are mainly reflecting reduced adipose tissue insulin sen-
sitivity rather than any long-term change in insulin secretion. A similarly reduced capacity of
insulin to suppress free fatty acids production during a rigorous hyperinsulinaemic-euglycae-
mic clamp carried out early in adult life has been measured in small-for-gestational-age
humans (SGA, birthweight <3rd centile, [54]), and was likewise independent of any major
impairment in insulin secretion. In the present study, greater NEFA concentrations (fasting
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and AUC during the GTT) were evident at 7 weeks postnatal suggesting that altered lipid
metabolism is an early presage of adverse metabolic health in the low birthweight animals.
High peripheral lipid concentrations and other indicators of insulin resistance (measured
directly and indirectly) are correspondingly reported in babies and young children defined as
SGA at birth but the risk of exhibiting these metabolic disease indicators is largely confined to
individuals who display rapid catch-up growth in early postnatal life [59]. Ninety-one percent
of the prenatally growth-restricted animals studied here had faster relative growth compared
with normally grown controls during the suckling phase and as a group they failed to
completely catch-up by study end (modestly lower height and weight, [35]). Accordingly, both
birthweight and the relative rate of early growth were strongly associated with lipid metabo-
lism/insulin sensitivity during the glucose tolerance test close to study end.
The higher circulating NEFA concentrations in growth-restricted versus control female off-
spring at each age studied was matched by higher PAT expression of the lipolytic HSL gene at
study end. Similarly, the greater body fat percentage and PAT mass in these growth-restricted
females was reflected by higher gene expression of key adipokines, namely leptin and adipo-
nectin. While the elevated PPARᵧ expression is arguably commensurate with continuing adi-
pose tissue expansion in growth-restricted females, the unchanged expression of genes
involved in fat storage, namely G3PDH, LPL and FASN suggests that maximum lipogenesis
had already been achieved by mid-adult life. Indeed, the DEXA measurement indicates that
two thirds of the growth-restricted females had exceeded fifty percent body fat by this stage.
Others have reported an increase in adipose tissue LPL expression in similarly aged sheep
exposed to early gestation undernutrition: in this case the difference was specific to males and
independent of any observed change in body fatness [52]. Clearly measuring gene expression
in a single fat depot and on a single occasion only provides a snapshot of the underlying molec-
ular physiology. Moreover, our focus here was the adipose tissue and we are cognisant that
expression may differ in other insulin-sensitive tissues such as skeletal muscle and liver.
Fetal/offspring sex, adiposity and perirenal fat gene expression
To our knowledge this is the first ovine study sufficiently powered at the outset to enable the
impact of fetal sex on adipose tissue phenotype and gene expression to be measured. Accord-
ingly, relative to male fetuses, females had a higher body-weight-specific PAT mass with more
multilocular adipocytes, and PAT leptin gene expression was greater irrespective of prenatal
growth category. The latter confirms a prior (but underpowered) observation in the under-
nourished model [22]. This sexual dimorphism in ovine prenatal adipose tissue development
and adipokine gene expression is perhaps unsurprising given that female sex in humans is
associated with higher leptin concentrations in amniotic fluid at 16 weeks gestation and in
cord blood at delivery [66,67], and with greater percentage body fat neonatally [68]. Leptin is
likely to underlie the sex difference in adipocyte phenotype reported herein as leptin infusion
for 4 days in late gestation sheep fetuses (of unspecified sex) increased the proportion of multi-
locular cells in PAT, while the amount of UCP1 protein also tended to be higher [69]. Notably,
within the growth-restricted fetuses studied here, females had the highest UCP1 gene expres-
sion suggestive of a temporal advance in adipose tissue development and potential thermo-
genic capacity compared with similarly-sized males. Indeed, the greater PAT expression of
IGF1 in males, a gene we have shown to be most highly expressed at an earlier stage of adipo-
cyte proliferation and differentiation in mid-gestation [22], further aligns with a relative delay
in adipose tissue development in this gender. These sex differences in fetal fat status may play
a role in the lower Appearance, Pulse, Grimace, Activity and Respiration (APGAR) scores and
poorer neonatal outcomes observed in male babies across settings [70–73]. The origin of the
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dimorphism in prenatal adipose tissue development in both sheep and humans is likely to be
differences in circulating sex steroid concentrations as the gonads of both species are steroido-
genically-active from the point of sexual differentiation in early pregnancy [74,75]. Oestrogen
receptors (ERα, ERβ) are present in the brown fat of human fetuses at mid- pregnancy, and
ERα expression increases with gestational age over the range 15 to 23 weeks suggestive of a
role for oestrogen in adipose tissue differentiation [76]. Similarly, the visceral fat of sheep
fetuses express these receptors at mid (day 90, [77]) and later (day120, [78]) gestation and
abundance is enhanced in females when fetal oestrogen concentrations are increased as a con-
sequence of maternal testosterone treatment (model of polycystic ovary syndrome, [77,79]).
The effect of female sex on adiposity extends across the life-course. Regression analysis of
serial DEXA data in contemporaneously exposed offspring in the current postnatal study
revealed that females were approximately 70% fatter than males at birth, independent of prena-
tal growth. This wholly aligns with prior observations of greater internal fat mass, chemical car-
cass fat content, adipocyte size and expression of genes involved in lipogenesis and adipokine
signalling in females compared with males necropsied at 11 weeks postnatal age [29,30], and
supports the concept that females partition more nutrients into fat from the earliest stages of
adipose tissue development. Given the large sex-difference in adiposity by the time the lambs
are born, it is unsurprising that plasma leptin concentrations diverged soon after and were per-
sistently higher in females, reflecting their greater body fat throughout most of the life-course.
Maximum leptin concentrations were reached in females at an earlier stage of adult life than in
males in line with reported sex differences in the rate of skeletal growth, fat deposition, bone
density accrual and the attainment of mature body size [35, current study]. Thus, females reach
a smaller adult size but are closer to maximum body fatness earlier than males. In contrast,
even at two years of age and relative to normal females, normal birthweight males are continu-
ing to deposit fat as indicated by their higher rate of fat accrual overall, albeit from a lower base-
line, and greater body weight specific renal fat mass at necropsy. The robustly higher PAT
expression of PPARɤ;, and genes involved in fat deposition (LPL, FASN), metabolism (HSL)
and adipocyte signalling (leptin, adiponectin) in males at this age, irrespective of prenatal
growth trajectory, corresponds with the premise of a still active and dynamic fat depot.
In summary, we have shown that growth-restricted fetuses have a relatively fat phenotype
by late gestation and lipid metabolism is negatively perturbed across the life-course in both
sexes when nutrients are abundant postnatally in contemporaneous animals. Sexual dimor-
phism in adiposity originates in fetal life and persists thereafter, and accordingly it is growth-
restricted females that are overtly obese by mid-adult life. While the influence of offspring sex
is more likely to be permanent the effect of prenatal growth-restriction on lipid metabolism
may be amenable to postnatal dietary manipulation and requires to be tested.
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